News

News: Xenon unable to Pass 2b Trials $XENE

Teva Pharmaceutical Industries Ltd. and Xenon Pharmaceuticals Inc., has jointly conducted the placebo-controlled Phase 2b study designed to evaluate the safety and efficacy of topically applied TV-45070 (4% and 8% w/w ointment) in patients with chronic pain due to osteoarthritis (OA) of the knee. The results were not sufficient to make any difference from placebo in

News: Xenon unable to Pass 2b Trials $XENE Read More »

News: Biocept Launched Liquid Biopsy Test $BIOC

Biocept, Inc., a molecular diagnostics company, has launched liquid Biopsy test for Breast and Lungs Cancer. It will help physicians identify patients who may be receptive to certain breast and lung cancer treatments. “The launch of FGFR1 testing is part of our strategy to use liquid biopsy to transform the field of personalized medicine,” said Raaj Trivedi,

News: Biocept Launched Liquid Biopsy Test $BIOC Read More »

News: Shell Midstream acquires Poseidon Oil $SHLX

Shell Midstream Partners has acquired a 36% equity interest in the Poseidon Oil Pipeline Co. The Deal accounts for $350 million from Equilon Enterprises LLC, a subsidiary of Shell Oil Products US. The acquisition was funded with borrowings under Shell Midstream Partners’ revolving credit facilities. Shell has also  increased its total borrowing capacity to $500 Million

News: Shell Midstream acquires Poseidon Oil $SHLX Read More »